mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.44 |
0.006 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.006 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.007 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.007 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.008 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.009 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.009 |